Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results

IRVINE, Calif., Nov. 11, 2021 — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic, mitochondrial diseases, today reported financial results for the quarter ended September 30, 2021 and provided an update on its clinical programs. “We continued to make good… Continue reading Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results